Printer Friendly
The Free Library
19,573,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

CEO INTERVIEW: ULF JONSSON - BIACORE INTERNATIONAL AB (BCOR).


(MAF MAF

macrophage activating factor.
224) ULF ULF
abbr.
ultralow frequency
 JONSSON - BIACORE INTERNATIONAL AB (BCOR). Describes the company's business and its background; prospects for the industry, with positive and negative trends; competitive threats; strategic opportunities for the firm including its marketing plans and acquisition potential; management strength and organization; and the financial prospects of the firm looking forward. Sector: Biotechnology. Published date 5/7/01. Tickers featured: BCOR. Complete text approximately 3000 words. Document # MAF224.

CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  INTERVIEWS, The Wall Street Transcript A generic term for any kind of copy, particularly an official or certified representation of the record of what took place in a court during a trial or other legal proceeding.

A transcript of record
, 67 Wall Street, NY 10005. Voice (212) 952 7433. Fax: (212) 668-9842. E-mail: transcript@twst.com.

***
COPYRIGHT 2001 Wall Street Transcript Corporation
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Comment:CEO INTERVIEW: ULF JONSSON - BIACORE INTERNATIONAL AB (BCOR).
Publication:Wall Street Transcript Digest
Geographic Code:4EUSW
Date:May 7, 2001
Words:89
Previous Article:CEO INTERVIEW: RUSSELL HAYS - BIOSOURCE INTERNATIONAL INC (BIOI).
Next Article:CEO INTERVIEW: STUART COLLINSON - AURORA BIOSCIENCES CORPORATION (ABSC).
Topics:



Related Articles
Broker and biacore partner for new technology. (Executive Briefing: News, Trends & Market Intelligence & Instrument Executives).
Executive changes. (Random Samples).
Biacore initiates business review and appoints new CEO.
Biacore acquires SPR Company.
Biacore to launch Biacore[R] T100--the most advanced system to date for protein interaction analysis.
The bottom line: data from recent industry financial reports. Dollar amounts in millions.
GE Healthcare to acquire Biacore for $390 million.
BIACORE OVERALL SALES INCREASED 21% IN 2ND QTR OF 2006.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles